comparemela.com
Latest Breaking News On - Aptamer immune stimulator conjugate - Page 1 : comparemela.com
Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201: A Promising Approach to Address Under Medical Needs
/PRNewswire/ Aptamer Sciences Inc. (KOSDAQ, 291650) announced the filing of an Investigational New Drug (IND) application for the phase 1 clinical trial of.
Seongnam
Kyonggi-do
South-korea
Han
Hong-jae-chon
Aprc-aptamer-radioligand
National-cancer-center
Aptamer-sciences-inc
Bundang-medical-center
Samsung-medical-center
Korean-ministry-of-food
Aptamer-sciences
vimarsana © 2020. All Rights Reserved.